| For: | Ridruejo E, Pereson MJ, Flichman DM, Di Lello FA. Hepatitis C virus treatment failure: Clinical utility for testing resistance-associated substitutions. World J Hepatol 2021; 13(9): 1069-1078 [PMID: 34630875 DOI: 10.4254/wjh.v13.i9.1069] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i9/1069.htm |
| Number | Citing Articles |
| 1 |
Ming-Ying Lu, Chung-Feng Huang, Chao-Hung Hung, Chi‐Ming Tai, Lein-Ray Mo, Hsing-Tao Kuo, Kuo-Chih Tseng, Ching-Chu Lo, Ming-Jong Bair, Szu-Jen Wang, Jee-Fu Huang, Ming-Lun Yeh, Chun-Ting Chen, Ming-Chang Tsai, Chien-Wei Huang, Pei-Lun Lee, Tzeng-Hue Yang, Yi-Hsiang Huang, Lee-Won Chong, Chien-Lin Chen, Chi-Chieh Yang, Sheng‐Shun Yang, Pin-Nan Cheng, Tsai-Yuan Hsieh, Jui-Ting Hu, Wen-Chih Wu, Chien-Yu Cheng, Guei-Ying Chen, Guo-Xiong Zhou, Wei-Lun Tsai, Chien-Neng Kao, Chih-Lang Lin, Chia-Chi Wang, Ta-Ya Lin, Chih‐Lin Lin, Wei-Wen Su, Tzong-Hsi Lee, Te-Sheng Chang, Chun-Jen Liu, Chia-Yen Dai, Jia-Horng Kao, Han-Chieh Lin, Wan-Long Chuang, Cheng-Yuan Peng, Chun-Wei- Tsai, Chi-Yi Chen, Ming-Lung Yu. Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program. Clinical and Molecular Hepatology 2023; 30(1): 64 doi: 10.3350/cmh.2023.0287
|
| 2 |
Kaley Tash, Victor Javier Rivera-Santiago, Jamie P. Morano. Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century. 2024; : 91 doi: 10.1007/978-3-031-57369-9_7
|
| 3 |
Malik Sallam, Roaa Khalil. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review. Microorganisms 2024; 12(6): 1035 doi: 10.3390/microorganisms12061035
|
| 4 |
Fredejah T. Royer, Jeremy C. Burton, Johnathan Burns, Megan G. Lloyd, Reuben Onwe, Jennifer F. Moffat, Neil J. Grimsey. Small Molecule Targeting of Atypical p38 Protects Against Viral Infection. The FASEB Journal 2025; 39(20) doi: 10.1096/fj.202501847
|
| 5 |
Alexis Jose-Abrego, Saul Laguna-Meraz, Sonia Roman, Irene M. Mariscal-Martinez, Arturo Panduro. Hepatitis C Virus Resistance-Associated Substitutions in Mexico. Viruses 2025; 17(2): 169 doi: 10.3390/v17020169
|
| 6 |
Cristina Burgui, Ramón San Miguel, Silvia Goñi-Esarte, Regina Juanbeltz, Juan Isidro Úriz-Otano, Jesús Reparaz, Maite Sarobe, José Manuel Zozaya, Jesús Castilla. Effectiveness of hepatitis C antiviral treatment and feasibility of hepatitis C elimination goal. Postgraduate Medicine 2023; 135(4): 352 doi: 10.1080/00325481.2022.2141499
|
| 7 |
Roaa Khalil, Kholoud Al-Mahzoum, Muna Barakat, Malik Sallam. An Increase in the Prevalence of Clinically Relevant Resistance-Associated Substitutions in Four Direct-Acting Antiviral Regimens: A Study Using GenBank HCV Sequences. Pathogens 2024; 13(8): 674 doi: 10.3390/pathogens13080674
|
